Simple animal models for amyotrophic lateral sclerosis drug discovery. - RIIP - Réseau International des Instituts Pasteur Access content directly
Journal Articles Expert Opinion on Drug Discovery Year : 2016

Simple animal models for amyotrophic lateral sclerosis drug discovery.


Simple animal models have enabled great progress in uncovering the disease mechanisms of amyotrophic lateral sclerosis (ALS) and are helping in the selection of therapeutic compounds through chemical genetic approaches. Within this article, the authors provide a concise overview of simple model organisms, C. elegans, Drosophila and zebrafish, which have been employed to study ALS and discuss their value to ALS drug discovery. In particular, the authors focus on innovative chemical screens that have established simple organisms as important models for ALS drug discovery. There are several advantages of using simple animal model organisms to accelerate drug discovery for ALS. It is the authors' particular belief that the amenability of simple animal models to various genetic manipulations, the availability of a wide range of transgenic strains for labelling motoneurons and other cell types, combined with live imaging and chemical screens should allow for new detailed studies elucidating early pathological processes in ALS and subsequent drug and target discovery.
No file

Dates and versions

pasteur-01351530 , version 1 (03-08-2016)



Shunmoogum A Patten, J Alex Parker, Xiao-Yan Wen, Pierre Drapeau. Simple animal models for amyotrophic lateral sclerosis drug discovery.. Expert Opinion on Drug Discovery, 2016, 11 (8), pp.797-804. ⟨10.1080/17460441.2016.1196183⟩. ⟨pasteur-01351530⟩


17 View
0 Download



Gmail Facebook Twitter LinkedIn More